The process was also informed by multiple surveys of membership and elected leadership.

Five key strategic issues were identified: advocacy, education, innovation and improved patient care, governance, and management. This plan effectively sets helping goals for the Association, along with detailed objectives for the existing year, and broader goals for another four years. Molecular pathology can be coming to getting central to the practice of medication, as molecular diagnostics proceeds to guide more customized and accurate treatments, said Strategic Planning Implementation Committee Chair Dr. Karen Mann. AMP intends to use its influence and the knowledge of its associates to provide education and promote plans that will enhance patient treatment. AMP announced an growth of its personnel also, including Director of Scientific Programs Melvin Limson, Project and PhD Coordinator TaNika Switzer.In addition to gathering data on the usage of CAM practices, the study sought information regarding why people use CAM also. Key results suggest that: 55 % of adults said these were most likely to use CAM because they believed that it would help them when combined with conventional medical treatments; 50 % thought CAM will be interesting to try; 26 % used CAM just because a conventional medical expert suggested they try it; and 13 % used CAM because they sensed that typical medicine was too expensive. Interestingly, the survey also discovered that about 28 % of adults used CAM because they believed conventional medical treatments wouldn’t normally help them with their health problem; this is in contrast to previous findings that CAM users aren’t, in general, dissatisfied with conventional medicine.